Relmada Therapeutics Overview
Relmada Therapeutics Target Price
Analysts' 12-month price predictions for RLMD.
Get informed when a big investor buys or sells
+ FollowShare Price
$6.33
Average Target Price
$10.00
58% upside
58% upside1 analysts in the last 4 months
High: $10 | Low: $10
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-03-13 | Mizuho SecuritiesUy Ear | $10 | 58% upside |  |
| 2026-01-23 | Leerink Partners | $8 | 26.4% upside | |
| 2025-12-22 | Jefferies | $9 | 42.2% upside | |
| 2024-06-05 | Goldman SachsAndrea Tan | $2 |  68.4% downside | |
| 2022-10-13 | JefferiesAndrew Tsai | $8 | 26.4% upside | |
| 2022-10-13 | OppenheimerJay Olson | $7 | 10.6% upside | |